2014 Program

Mon, 11/17

7:00 AM – 7:50 AM
7:50 AM – 8:00 AM
Time=Lives Talk: Not if, when
  • Eric Minikel
    Co-Director, Prion Alliance
  • Sonia Vallabh
    Co-Director, Prion Alliance; PhD program, Biological and Biomedical Sciences, Harvard Medical School
8:00 AM – 9:00 AM
Plenary: The future of U.S. research leadership
  • Manny Alvarez
    Senior Managing Editor, Health News, Fox News; Chairman, Department of Obstetrics and Gynecology, Hackensack University Medical Center

  • Anna Barker
    Professor and Director, Transformative Healthcare Networks; Co-Director, Complex Adaptive Systems Network, Arizona State University
  • The Honorable Diana DeGette
    Chief Deputy Whip, U.S. House of Representatives
  • Laurie Glimcher
    Dean, Weill Cornell Medical College
  • Michael Milken
    Chairman, Milken Institute; Founder, FasterCures
  • The Honorable Fred Upton
    Chairman, Committee on Energy and Commerce, U.S. House of Representatives
9:15 AM – 10:10 AM
Playing nice in the sandbox: Can research-by-consortium accelerate progress against disease?
  • Mark Lim
    Associate Director, Medical Research Innovation, FasterCures

  • Dana Ball
    Executive Director and Co-Founder, T1D Exchange; CEO, Unitio, Inc.
  • Martha Brumfield
    President & CEO, Critical Path Institute
  • ShaAvhrée Buckman-Garner
    Director, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • Michel Goldman
    Director, Innovative Medicines Initiative
  • Eckhard Leifke
    Global Head of Development, Diabetes, Sanofi
Pulling back the curtain on clinical trials data
  • Jonathan Simons
    President and CEO, Prostate Cancer Foundation

  • Gregory Curt
    Chairman, Life Sciences Consortium, CEO Roundtable on Cancer; Executive Director, US Medical Affairs, AstraZeneca
  • Craig Lipset
    Head, Clinical Innovation, Worldwide Research & Development, Pfizer Inc.
  • Joseph Ross
    Assistant Professor, General Internal Medicine, Yale University School of Medicine
  • Katherine Wilemon
    Founder and CEO, FH Foundation
Unlocking the mysteries of the human brain
  • Kafui Dzirasa
    Assistant Professor, Department of Psychiatry and Behavioral Sciences, Center for Neuroengineering, Duke University Medical Center

  • Meryl Comer
    President, Geoffrey Beene Foundation Alzheimer's Initiative; Founder, WomenAgainstAlzheimers
  • Deborah Dunsire
    President & CEO, FORUM Pharmaceuticals
  • Magali Haas
    Founder and CEO, Orion Bionetworks
  • Allan Jones
    CEO, Allen Institute for Brain Science
  • Reisa Sperling
    Director, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital; Professor of Neurology, Harvard Medical School
12:00 PM – 12:30 PM
12:30 PM – 12:40 PM
Time=Lives Talk: The race to the starting line
  • Isaac Kinde
    MD-PhD Candidate, Johns Hopkins University
12:40 PM – 1:40 PM
Plenary: The future of medical innovation: Beyond our wildest dreams?
  • Francis Collins
    Director, National Institutes of Health

  • Sangeeta Bhatia
    Director, Laboratory for Multiscale Regenerative Technologies and Professor, Massachusetts Institute of Technology
  • B. Bonin Bough
    Vice President, Global Media and Consumer Engagement, Mondelez International
  • Atul Butte
    Chief of the Division of Systems Medicine and Associate Professor of Pediatrics, Medicine, and Computer Science, Stanford University
  • Rudolph Tanzi
    Director, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease; Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School
  • Dan Wattendorf
    Program Manager, Biological Technologies Office, Defense Advanced Research Projects Agency
1:55 PM – 2:50 PM
Entrepreneurs for Cures
  • Daniel Gorfine
    Director, Financial Markets Policy and Legal Counsel, Milken Institute

  • Esther Dyson
    Founder, HICCup
  • Craig Lipset
    Head, Clinical Innovation, Worldwide Research & Development, Pfizer Inc.
  • Aenor Sawyer
    Associate Director, Strategic Relations, Center for Digital Health Innovation; Director, Skeletal Health Service, University of California, San Francisco
3:55 PM – 4:50 PM
Integrating PHD (personal health data) in medical R&D
  • Todd Sherer
    CEO, The Michael J. Fox Foundation for Parkinson's Research

  • Eric Green
    Director, National Human Genome Research Institute, National Institutes of Health
  • Anna McCollister-Slipp
    Co-Founder, Galileo Analytics
  • Tom Parsons
    Co-Founder, HealthXL
  • Eric Schadt
    Director of the Icahn Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences, and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine, Mount Sinai
  • Ravi Seshadri
    Vice President, Technology, NantHealth
Is disruptive innovation of clinical trials possible?
  • Amy Dockser Marcus
    Staff Reporter, The Wall Street Journal

  • Pablo Cagnoni
    President, Onyx Pharmaceuticals, Inc.
  • Angela DeMichele
    Co-Leader, Breast Cancer Research Program, Perelman School of Medicine, University of Pennsylvania
  • John Reites
    Senior Director, Health Engagement and Communications, Quintiles
  • Tomasz Sablinski
    CEO, Transparency Life Sciences
  • Ellen Sigal
    Chair and Founder, Friends of Cancer Research
The power behind the 'p': PROs, patient preference, and patient-centered outcomes research
  • Kim McCleary
    Director, Strategic Initiatives, FasterCures

  • Ethan Basch
    Director, Cancer Outcomes Research Program; Associate Professor, Medicine and Public Health, UNC-Chapel Hill, Cancer Prevention and Control
  • Patricia Furlong
    President and CEO, Parent Project Muscular Dystrophy
  • Michelle McMurry-Heath
    Senior Director, Regulatory Strategy and Policy, FaegreBD Consulting
  • Richard Pops
    Chairman and CEO, Alkermes
  • Joe Selby
    Executive Director, Patient-Centered Outcomes Research Institute
5:00 PM – 6:30 PM

Tue, 11/18

7:00 AM – 8:00 AM
8:00 AM – 8:55 AM
Democratizing science
  • Jessica Richman
    CEO, uBiome

  • Darlene Cavalier
    Founder, SciStarter
  • Andrea Downing
    BRCActivist, Founder, Brave Bosom
  • Ethan Perlstein
    Founder, Perlstein Lab PBC
  • Brock Reeve
    Executive Director, Harvard Stem Cell Institute; President, Poliwogg Regenerative Medicine Fund
The blurring boundary between the university and the marketplace
  • LaTese Briggs
    Associate Director, Philanthropy Advisory Service, FasterCures

  • Lynda Chin
    Department Chair, Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
  • Michael Foley
    Director, Tri-Institutional Therapeutics Discovery Institute
  • Gary Gibbons
    Director, National Heart, Lung, and Blood Institute, National Institutes of Health
  • Melinda Richter
    Head, Janssen Labs, Johnson & Johnson
The price of innovation: Who defines 'value'?
  • Roger Longman
    CEO, Real Endpoints

  • Peter Bach
    Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
  • Cartier Esham
    Executive Vice President, Emerging Companies, Biotechnology Industry Organization
  • Louis Jacques
    Senior Vice President and Chief Clinical Officer, ADVI
  • Michael Kolodziej
    National Medical Director, Oncology Solutions, Office of the Chief Medical Officer, Aetna
  • Brian Rosen
    Chief Policy, Advocacy & Patient Access Officer, Leukemia & Lymphoma Society
11:00 AM – 11:55 AM
(Re)defining impact: Assessing biomedical research investments
  • Beth Meagher
    Principal, Deloitte Consulting LLP

  • Annette Bakker
    President and Chief Scientific Officer, Children's Tumor Foundation
  • Richard Hodes
    Director, National Institute on Aging, National Institutes of Health
  • Thomas Luby
    Senior Director, New Ventures, Johnson & Johnson Innovation Center, Boston
  • Benjamin Seet
    Executive Director, Biomedical Research Council, A*STAR
Collaborative capital
  • Melissa Stevens
    Deputy Executive Director, FasterCures

  • Michelle Dipp
    Co-Founder & CEO, OvaScience; Founder and Partner, Longwood Fund
  • Esther Dyson
    Founder, HICCup
  • Jit Patel
    Vice President, Research Business Development, JDRF
  • Katherine Priestley
    Managing Partner, Park Vale Capital
  • Sean Schantzen
    Co-Founder, Healthfundr
Man v. microbes: Can we win the war against antibiotic resistance?
  • Luke Timmerman
    Biotechnology Journalist

  • Steven Gilman
    Chief Scientific Officer and Executive Vice President, Research & Development, Cubist Pharmaceuticals Inc.
  • William Hanlon
    Vice President, Head of Global Regulatory Affairs, Covance
  • Luciano Marraffini
    Assistant Professor and Head, Laboratory of Bacteriology, The Rockefeller University
  • Jean Patel
    Deputy Director, Office of Antimicrobial Resistance, Centers for Disease Control and Prevention
  • Charlene Reed
    CEO, The Foundation to Combat Antimicrobial Resistance
12:15 PM – 12:45 PM
12:45 PM – 12:55 PM
Time=Lives Talk: The business of fixing disease
  • Ilan Ganot
    Founder and CEO, Solid Ventures
12:55 PM – 1:55 PM
Plenary: Is the biopharma industry fit for the future?
  • Kate Rawson
    Senior Editor, Prevision Policy LLC

  • Mark Alles
    President and Chief Operating Officer, Celgene Corporation
  • James Geraghty
    Entrepreneur-in-Residence, Third Rock Ventures
  • Joanna Horobin
    Chief Medical Officer, Verastem, Inc.
  • Brad Margus
    CEO, Exigence Neurosciences
  • Mark Murcko
    Lecturer, Department of Biological Engineering, MIT; Senior Vice President of Strategy, Schrodinger; Principal, Disruptive Biomedical, LLC
3:20 PM – 3:30 PM
Time=Lives Talk: The perfect storm
  • Debra Black
    Co-Founder and Board Chair, Melanoma Research Alliance
  • Suzanne Topalian
    Professor of Surgery and Oncology, and Director, Melanoma Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University